QuidelOrtho Corp (QDEL)
40.16
+2.27
(+5.99%)
USD |
NASDAQ |
Nov 22, 12:36
QuidelOrtho Debt to Equity Ratio: 0.8003 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.8003 |
| June 30, 2024 | 0.8078 |
| March 31, 2024 | 0.7262 |
| December 31, 2023 | 0.4824 |
| September 30, 2023 | 0.4968 |
| June 30, 2023 | 0.5029 |
| March 31, 2023 | 0.5178 |
| December 31, 2022 | 0.5347 |
| September 30, 2022 | 0.5609 |
| June 30, 2022 | 0.5572 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.0004 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.0079 |
| June 30, 2020 | 0.0656 |
| March 31, 2020 | 0.0211 |
| December 31, 2019 | 0.0226 |
| September 30, 2019 | 0.0388 |
| June 30, 2019 | 0.06 |
| March 31, 2019 | 0.1912 |
| December 31, 2018 | 0.2528 |
| September 30, 2018 | 0.3529 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.3643 |
| March 31, 2018 | 0.6862 |
| December 31, 2017 | 1.750 |
| September 30, 2017 | 0.6783 |
| June 30, 2017 | 0.6919 |
| March 31, 2017 | 0.6619 |
| December 31, 2016 | 0.7194 |
| September 30, 2016 | 0.7268 |
| June 30, 2016 | 0.7338 |
| March 31, 2016 | 0.7072 |
| December 31, 2015 | 0.6553 |
| September 30, 2015 | 0.6469 |
| June 30, 2015 | 0.611 |
| March 31, 2015 | 0.5539 |
| December 31, 2014 | 0.5631 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.025 |
| September 30, 2012 | 0.1018 |
| June 30, 2012 | 0.1034 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
0.8078
Maximum
Jun 2024
0.3052
Average
0.274
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.3764 |
| Becton Dickinson & Co | 0.7761 |
| Repligen Corp | 0.2586 |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 0.7605 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.801B |
| Total Liabilities (Quarterly) | 3.614B |
| Shareholders Equity (Quarterly) | 3.187B |
| Current Ratio | 1.375 |
| Net Debt Paydown Yield | -0.23% |